Allergy Diagnostics Reagent Market
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediate ... Read More
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report contains market size and forecasts of Protein and Peptide Therapeutics in Global, including the following market information:
Global Protein and Peptide Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Protein and Peptide Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Protein and Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein and Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein and Peptide Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Type, 2021 (%)
Injection
Oral
Global Protein and Peptide Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Application, 2021 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Protein and Peptide Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein and Peptide Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Protein and Peptide Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediate ... Read More
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediate ... Read More
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediate ... Read More
Smart bedsĀ use a sensor, placed under the mattress, to help prevent patient falls. Rather than j ... Read More